NEWS
Our Latest News
ARCHIMED finalizes the acquisition of IBA Lifesciences GmbH by Cube Biotech
ARCHIMED finalizes the acquisition of IBA Lifesciences GmbH by Cube Biotech
The acquisition represents a transformational transaction for Cube, bringing critical size, complementing Cube’s protein purification portfolio, reinforcing its market position and boosting its profitability.
ARCHIMED earns 5x its investment, selling a majority of Ad-Tech to Tokyo-listed Nihon Kohden
November
26,
2024
ARCHIMED acquires SeqCenter, a fast-growing player in cutting-edge DNA and RNA gene sequencing
November
8,
2024
ARCHIMED acquires FIM Medical, a leader in the vision, audio & respiratory medical devices market
October
15,
2024
368